OPSEU Pension Plan Trust Fund’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,655
Closed -$2.26M 37
2022
Q3
$2.26M Buy
8,655
+29
+0.3% +$6.16K 0.6% 34
2022
Q2
$1.75M Sell
8,626
-107
-1% -$21.9K 0.44% 72
2022
Q1
$1.86M Buy
8,733
+263
+3% +$57.2K 0.44% 78
2021
Q4
$2.07M Sell
8,470
-11
-0.1% -$2.83K 0.47% 65
2021
Q3
$2.39M Sell
8,481
-318
-4% -$104K 0.6% 28
2021
Q2
$3.07M Buy
8,799
+3,280
+59% +$994K 0.79% 13
2021
Q1
$1.54M Buy
5,519
+139
+3% +$37.5K 0.4% 96
2020
Q4
$1.31M Sell
5,380
-2,436
-31% -$628K 0.37% 113
2020
Q3
$2.19M Buy
7,816
+701
+10% +$196K 0.68% 24
2020
Q2
$1.86M Buy
+7,115
New +$2.14M 0.64% 28

Other funds holding BIIB

OPSEU Pension Plan Trust Fund's BIIB Position: Q4 2022 in Review

OPSEU Pension Plan Trust Fund sold out of Biogen (BIIB) in Q4 2022, closing a stake of 8,655 shares — an estimated $2.26M sold.

OPSEU Pension Plan Trust Fund first reported a position in BIIB in Q2 2020 and held it in 10 quarters. The position peaked at $3.07M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • OPSEU Pension Plan Trust Fund reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • OPSEU Pension Plan Trust Fund sold 8,655 Biogen shares in Q4 2022, an estimated $2.26M.
  • OPSEU Pension Plan Trust Fund first reported a position in Biogen in Q2 2020 and held it in 10 quarters.
  • OPSEU Pension Plan Trust Fund's Biogen position peaked at $3.07M in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q4 2022, filed 9 Feb 2023.